Published on .

American Home Products predicted it will underperform analyst expectations for 1999 and blamed poor sales of its crop-protection and livestock-health products. AHP's bid to shore up those businesses by merging with Monsanto Corp. was terminated in October. AHP is eyeing "strategic alternatives" for the product lines. In its key pharmaceuticals business, AHP said its new-product pipeline "is the strongest in the company's history." After sharp early-week losses, AHP stock closed Friday at 56.31, down 2.27% for the
Most Popular
In this article: